The Science and Coordination Challenges in Influenza Vaccine Development
An excerpt from the Sabin Aspen Vaccine Science & Policy Group report, “Accelerating the Development of a Universal Influenza Vaccine”.
In this white paper from the report, “Accelerating the Development of a Universal Influenza Vaccine”, author Heather Youngs and her team deliver findings from literature reviews and interviews with researchers and funders. The paper examines the R&D landscape and details areas that need additional scientific advances including;
- Tracking Infectious Diseases and Identifying New Pathogens
- Antigen Discovery
- Candidate Vaccine Formulation
- Pre-clinical Testing
- Clinical Trials
- Scale-Up of Vaccine Production
- Vaccine Production
Heather Youngs, Ph.D., is a program officer and one half of the science team at the
Open Philanthropy Project. Since its inception 2 years ago, the team has recommended $120 million in grants and investments to support basic and translational science. Prior to joining Open Philanthropy, Youngs was director of the Bakar Fellows Program for faculty entrepreneurs at the University of California, Berkeley, a senior strategic advisor at the Energy Biosciences Institute at the University of California, Berkeley, and an assistant professor at Michigan Technological University.